Curto Sánchez E., Ojanguren Arranz Í., Blanco-Aparicio M., Crespo-Lessmann A., Plaza Moral V., Cisneros Serrano C., Serrano Pariente J.. How to Approach Non Eosinophilic Asthma? Results of a Survey Conducted by the SEPAR Emerging Asthma Group. Open Respiratory Archives. 2022; 4(1)DOI:10.1016/j.opresp.2021.100149. PMID:. IF:(Q/D).

Martinez-Garcia M.A., Oscullo G., Ponce S., Pastor E., Orosa B., Catalán P., Martinez A., Hernandez L., Muriel A., Chiner E., Vigil L., Carmona C., Mayos M., Garcia-Ortega A., Gomez-Olivas J.D., Beauperthuy T., Bekki A., Gozal D.. Effect of continuous positive airway pressure in very elderly with moderate-to-severe obstructive sleep apnea pooled results from two multicenter randomized controlled trials. SLEEP MEDICINE. 2022; 89DOI:10.1016/j.sleep.2021.11.009. PMID:34915264. IF:4.800(Q1/3D).

Cozzi-Lepri A., Peters L., Pelchen-Matthews A., Neesgaard B., Stephan C., Elbirt D., Brännström J., Paduta D., Trofimova T., Szlavik J., Van Eygen V., Pai H., Lundgren J., Harxhi A., Losso M., Kundro M., Schmied B., Karpov I., Vassilenko A., Paduto D., Mitsura V.M., Clumeck N., De Wit S., Delforge M., Hadziosmanovic V., Begovac J., Machala L., Jilich D., Gerstoft J., Pedersen C., Sedlacek D., Kronborg G., Benfield T., Johansen I.S., Ostergaard L., Wiese L., Moller N.F., Nielsen L.N., Zilmer K., Smidt J., Aho I., Viard J.P., Girard P.M., Pradier C., Fontas E., Duvivier C., Rockstroh J., Degen O., Hoffmann C., Stellbrink H.J., Stefan C., Bogner J., Fätkenheuer G., Chkhartishvili N., Sambatakou H., Adamis G., Paissios N., Uzdaviniene V., Staub T., Dragas S., Reiss P., Trajanovska J., Reikvam D.H., Maeland A., Bruun J., Knysz B., Szetela B., Inglot M., Bakowska E., Flisiak R., Grzeszczuk A., Parczewski M., Maciejewska K., Aksak-Was B., Beniowski M., Mularska E., Jablonowska E., Kamerys J., Wojcik K., Mozer-Lisewska I., Rozplochowski B., Zagalo A., Radoi R., Oprea C., Yakovlev A., Trofimora T., Khromova I., Kuzovatova E., Borodulina E., Vdoushkina E., Ranin J., Tomazic J., Miro J.M., Laguno M., Martinez E., Garcia F., Blanco J.L., Martinez-Rebollar M., Mallolas J., Callau P., Rojas J., Moreno S., del Campo S., Jou A., Paredes R., Puig J., Llibre J.M., Santos J.R., Domingo P., Gutierrez M., Mateo G.M., Sambeat A., Laporte J.M., Svedhem V., Thalme A., Sonnerborg A., Flamholc L., Kusejko K., Weber R., Calmy A., Furrer H., Battegay M., Schmid P., Kuznetsova A., Mikhalik J., Sluzhynska M., Milinkovic A., Johnson A.M., Simons E., Edwards S., Phillips A.M., Johnson A., Mocroft A., Orkin C., Winston A., Clarke A., Leen C.. Observational cohort study of rilpivirine (RPV) utilization in Europe. AIDS Research and Therapy. 2022; 19(1)DOI:10.1186/s12981-022-00457-0. PMID:35933352. IF:2.200(Q4/8D).

Martin-Iguacel R., Reyes-Urueña J., Bruguera A., Aceitón J., Díaz Y., Moreno-Fornés S., Domingo P., Burgos-Cibrian J., Tiraboschi J.M., Johansen I.S., Álvarez H., Miró J.M., Casabona J., Llibre J.M.. Determinants of long-term survival in late HIV presenters: The prospective PISCIS cohort study. Eclinicalmedicine. 2022; 52DOI:10.1016/j.eclinm.2022.101600. PMID:35958520. IF:15.100(Q1/1D).

Garreta E., Prado P., Stanifer M.L., Monteil V., Marco A., Ullate-Agote A., Moya-Rull D., Vilas-Zornoza A., Tarantino C., Romero J.P., Jonsson G., Oria R., Leopoldi A., Hagelkruys A., Gallo M., González F., Domingo-Pedrol P., Gavaldà A., del Pozo C.H., Hasan Ali O., Ventura-Aguiar P., Campistol J.M., Prosper F., Mirazimi A., Boulant S., Penninger J.M., Montserrat N.. A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells. Cell Metabolism. 2022; 34(6)DOI:10.1016/j.cmet.2022.04.009. PMID:35561674. IF:29.000(Q1/1D).

Trickey A., Zhang L., Gill M.J., Bonnet F., Burkholder G., Castagna A., Cavassini M., Cichon P., Crane H., Domingo P., Grabar S., Guest J., Obel N., Psichogiou M., Rava M., Reiss P., Rentsch C.T., Riera M., Schuettfort G., Silverberg M.J., Smith C., Stecher M., Sterling T.R., Ingle S.M., Sabin C.A., Sterne J.A.C.. Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort study. Lancet HIV. 2022; 9(6)DOI:10.1016/S2352-3018(22)00046-7. PMID:35659335. IF:(Q/D).

Riancho J.A., Peris P., González-Macías J., Pérez-Castrillón J.L., Cannata Andía J., Cano A., Carbonell Abella C., Casado Burgos E., Ciria Recasens M., Corral-Gudino L., del Pino Montes J., Del Río Barquero L.M., Díaz Curiel M., Díez Pérez A., García Vadillo A., Gómez Alonso C., Gómez de Tejada Romero M.J., Guañabens N., Hawkins Carranza F., Jódar Gimeno E., Malouf Sierra J., Martínez Díaz-Guerra G., Monegal Brancos A., Muñoz Torres M., Naves Díaz M., Nogues X., Nolla J.M., Olmos Martínez J.M., Peris Bernal P., Quesada Gómez J.M., Rodríguez García M., Sosa Henríquez M., Torrijos Eslava A., Valero Díaz de Lamadrid C.. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update). Revista De Osteoporosis Y Metabolismo Mineral. 2022; 14(1)DOI:10.4321/S1889-836X2022000100002. PMID:. IF:(Q/D).

Encarnacion, JA, Cerezuela, P, Espanol, I, Garcia, MR, Manso, C, De la Fuente, I, Garrigos, N, Viney, A, Minguillon, J, Surralles, J. Fanconi-like anemia related to a FANCM mutation. European Journal of Medical Genetics. 2022; 65(1)DOI:10.1016/j.ejmg.2021.104399. PMID:34793962. IF:1.900(Q4/8D).

Minguillon, J, Ramirez, MJ, Rovirosa, L, Bustamante-Madrid, P, Camps-Fajol, C, de Garibay, GR, Shimelis, H, Montanuy, H, Pujol, R, Hernandez, G, Bogliolo, M, Castillo, P, Soucy, P, Martrat, G, Gomez, A, Cuadras, D, Garcia, MJ, Gayarre, J, Lazaro, C, Benitez, J, Couch, FJ, Pujana, MA, Surralles, J. CDK5RAP3, a New BRCA2 Partner That Regulates DNA Repair, Is Associated with Breast Cancer Survival. Cancers. 2022; 14(2)DOI:10.3390/cancers14020353. PMID:35053516. IF:5.200(Q2/3D).

Webster A.L.H., Sanders M.A., Patel K., Dietrich R., Noonan R.J., Lach F.P., White R.R., Goldfarb A., Hadi K., Edwards M.M., Donovan F.X., Hoogenboezem R.M., Jung M., Sridhar S., Wiley T.F., Fedrigo O., Tian H., Rosiene J., Heineman T., Kennedy J.A., Bean L., Rosti R.O., Tryon R., Gonzalez A.-M., Rosenberg A., Luo J.-D., Carroll T.S., Shroff S., Beaumont M., Velleuer E., Rastatter J.C., Wells S.I., Surrallés J., Bagby G., MacMillan M.L., Wagner J.E., Cancio M., Boulad F., Scognamiglio T., Vaughan R., Beaumont K.G., Koren A., Imielinski M., Chandrasekharappa S.C., Auerbach A.D., Singh B., Kutler D.I., Campbell P.J., Smogorzewska A.. Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer. NATURE. 2022; 612(7940)DOI:10.1038/s41586-022-05253-4. PMID:36450981. IF:64.800(Q1/1D).

Errazquin R., Page A., Suñol A., Segrelles C., Carrasco E., Peral J., Garrido-Aranda A., Del Marro S., Ortiz J., Lorz C., Minguillon J., Surralles J., Belendez C., Alvarez M., Balmaña J., Bravo A., Ramirez A., Garcia-Escudero R.. Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia. ORAL ONCOLOGY. 2022; 134DOI:10.1016/j.oraloncology.2022.106184. PMID:36191479. IF:4.800(Q1/1D).

Blay, JY, Hindi, N, Bollard, J, Aguiar, S, Angel, M, Araya, B, Badilla, R, Bernabeu, D, Campos, F, Caro-Sanchez, CHS, Carvajal, B, Montoya, AC, Casavilca-Zambrano, S, Castro-Oliden, V, Chacon, M, Clara, M, Collini, P, Genoroso, RC, Costa, FD, Cuellar, M, dei Tos, AP, Malagon, HRD, Donati, D, Dufresne, A, Eriksson, M, Farias-Loza, M, Fernandez, P, Frezza, AM, Frisoni, T, Garcia-Ortega, DY, Gelderblom, H, Gouin, F, Gomez-Mateo, MC, Gronchi, A, Haro, J, Huanca, L, Jimenez, N, Karanian, M, Kasper, B, David, BBL, Lopez-Pousa, A, Lutter, G, Martinez-Said, H, Martinez-Tlahuel, J, Mello, CA, Perez, JMM, David, SM, Nascimento, AG, Ortiz-Cruz, EJ, Palmerini, E, Patel, S, Pfluger, Y, Provenzano, S, Righi, A, Rodriguez, A, Salas, R, Santos, TTG, Scotlandi, K, Soule, T, Stacchiotti, S, Valverde, C, Waisberg, F, Estrada, EZ, Martin-Broto, J. SELNET clinical practice guidelines for soft tissue sarcoma and GIST. CANCER TREATMENT REVIEWS. 2022; 102DOI:10.1016/j.ctrv.2021.102312. PMID:34798363. IF:11.800(Q1/1D).

Provencio, M, Rodriguez-Abreu, D, Ortega, AL, Serrano, G, Aguado, C, Franco, F, Gutierrez, V, Vivanco, GL, Guirado, M, Benitez, G, Estival, A, Calvo, V, Jimenez, B, Arasanz, H, Coves, J, Majem, M, Massuti, B, Vazquez, S, Juan-Vidal, O, Collazo-Lorduy, A, Gozalvez, CL, Del Barco, E, Rosero, A, Bosch-Barrerra, J, Moreno, MA, Mielgo-Rubio, X, Villa, JC, Lopez-Martin, A, Cordoba, JF, Aparisi, FD, Zafra, M, Mosquera, J, Altozano, JP, Nadal, E, Catot, S, Balsalobre, J, De Portugal, T, Martin, P, De Juan, SC, Cobo, M. Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study. Translational Lung Cancer Research. 2022; 11(1)DOI:10.21037/tlcr-21-504. PMID:35242627. IF:4.000(Q2/4D).

Kuemmel, S, Campone, M, Loirat, D, Lopez, RL, Beck, JT, De Laurentiis, M, Im, SA, Kim, SB, Kwong, A, Steger, GG, Adelantado, EZ, Duhoux, FP, Greil, R, Kuter, I, Lu, YS, Tibau, A, Ozguroglu, M, Scholz, CW, Singer, CF, Vega, E, Wimberger, P, Zamagni, C, Couillebault, XM, Fan, LQ, Guerreiro, N, Mataraza, J, Sand-Dejmek, J, Chan, A. A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer. CLINICAL CANCER RESEARCH. 2022; 28(1)DOI:10.1158/1078-0432.CCR-20-3955. PMID:34615719. IF:11.500(Q1/1D).

Adam, R, Tibau, A, Valiente, CM, Seruga, B, Ocana, A, Amir, E, Templeton, AJ. Clinical benefit of cancer drugs approved in Switzerland 2010-2019. PLoS One. 2022; 17(6)DOI:10.1371/journal.pone.0268545. PMID:35687539. IF:3.700(Q2/4D).

Hernandez, MH, Bote, V, Serra-LLovich, A, Cendros, M, Salazar, J, Mestres, C, Guijarro, S, Alvarez, A, Lamborena, C, Mendez, I, Sanchez, B, Hervas, A, Arranz, MJ. CES1 and SLC6A2 Genetic Variants As Predictors of Response To Methylphenidate in Autism Spectrum Disorders. Pharmacogenomics & Personalized Medicine. 2022; 15DOI:10.2147/PGPM.S377210. PMID:36393977. IF:1.900(Q4/9D).

Molto C., Tibau A., Bujosa A., Tapia J.C., Mittal A., Tamimi F., Amir E.. Association between control group therapy and magnitude of clinical benefit of cancer drugs. Scientific Reports. 2022; 12(1)DOI:10.1038/s41598-022-25983-9. PMID:36494465. IF:(Q/D).

Isla D., Majem M.. A Paradigm Shift for Resectable Non-Small Cell Lung Cancer. ARCHIVOS DE BRONCONEUMOLOGIA. 2022; 58(12)DOI:10.1016/j.arbres.2022.04.004. PMID:35595655. IF:8.000(Q1/2D).

Argilés G., Valladares-Ayerbes M., Viéitez J.M., García-Paredes B., Rodríguez-Garrote M., Rivera F., Goldberg R.M., Ciardiello F., Tabernero J.M., Goldberg R., Argilés, Tabernero J., Mulet N., Limón M.L., Valladares M., Jiménez P., Vieitez J.M., Grávalos C., García-Alfonso P., Santos C., Páez D., Tobeña M., Sastre J., García Paredes B., Benavides M., Aranda E., Cano M.T., Loupakis F., Rguez Garrote M., Guillén C., Rivera M.F., Safont J., Hiret S., Bennouna J., Pannier D., Malka D., Falcone A., Cremolini C., The. A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial). EUROPEAN JOURNAL OF CANCER. 2022; 177DOI:10.1016/j.ejca.2022.09.037. PMID:36335783. IF:8.400(Q1/2D).

Martin-Broto J., Redondo A., Moura D.S., Valverde C., Morales J.M., Lopez-Pousa A., Martinez-Trufero J., Gutierrez A., Díaz-Beveridge R., Luna P., Martinez-Marin V., Marcilla D., Arribas I., Ledesma P., Lopez-Martin J.A., Di Lernia D., Zamora J., Hindi N.. A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors. Nature Communications. 2022; 13(1)DOI:10.1038/s41467-022-33975-6. PMID:36271011. IF:16.600(Q1/1D).